Literature DB >> 16400246

Emotional learning and glutamate: translational perspectives.

Charles F Gillespie1, Kerry J Ressler.   

Abstract

Anxiety disorders are a common focus of clinical concern and certain forms of anxiety may be conceptualized as disorders of emotional learning. Behavior therapies effective in the treatment of anxiety are modeled on extinction training as a means of reducing pathological anxiety. The present understanding of human anxiety has been informed by preclinical research using rodent models to study the acquisition and extinction of fear. Glutamate appears to have a central role in both of these processes. The authors review this literature and discuss novel applications of D-cycloserine, a partial N-methyl-D-aspartate agonist, for the treatment of anxiety.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16400246      PMCID: PMC2764739          DOI: 10.1017/s1092852900010439

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  69 in total

1.  Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala.

Authors:  W A Falls; M J Miserendino; M Davis
Journal:  J Neurosci       Date:  1992-03       Impact factor: 6.167

2.  Extinction learning in humans: role of the amygdala and vmPFC.

Authors:  Elizabeth A Phelps; Mauricio R Delgado; Katherine I Nearing; Joseph E LeDoux
Journal:  Neuron       Date:  2004-09-16       Impact factor: 17.173

3.  Basic emotions, relations among emotions, and emotion-cognition relations.

Authors:  C E Izard
Journal:  Psychol Rev       Date:  1992-07       Impact factor: 8.934

Review 4.  Context and behavioral processes in extinction.

Authors:  Mark E Bouton
Journal:  Learn Mem       Date:  2004 Sep-Oct       Impact factor: 2.460

Review 5.  The role of the amygdala in fear and anxiety.

Authors:  M Davis
Journal:  Annu Rev Neurosci       Date:  1992       Impact factor: 12.449

6.  Acquisition of contextual Pavlovian fear conditioning is blocked by application of an NMDA receptor antagonist D,L-2-amino-5-phosphonovaleric acid to the basolateral amygdala.

Authors:  M S Fanselow; J J Kim
Journal:  Behav Neurosci       Date:  1994-02       Impact factor: 1.912

7.  Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.

Authors:  I M Marks; R P Swinson; M Başoğlu; K Kuch; H Noshirvani; G O'Sullivan; P T Lelliott; M Kirby; G McNamee; S Sengun
Journal:  Br J Psychiatry       Date:  1993-06       Impact factor: 9.319

8.  Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 blocks acquisition but not expression of fear-potentiated startle to an auditory conditioned stimulus.

Authors:  S Campeau; M J Miserendino; M Davis
Journal:  Behav Neurosci       Date:  1992-06       Impact factor: 1.912

9.  The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety.

Authors:  Chris S Busse; Jesse Brodkin; David Tattersall; Jeffery J Anderson; Noelle Warren; Lida Tehrani; Linda J Bristow; Mark A Varney; Nicholas D P Cosford
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

10.  Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala.

Authors:  M J Miserendino; C B Sananes; K R Melia; M Davis
Journal:  Nature       Date:  1990-06-21       Impact factor: 49.962

View more
  9 in total

Review 1.  Stress modulation of cognitive and affective processes.

Authors:  Serge Campeau; Israel Liberzon; David Morilak; Kerry Ressler
Journal:  Stress       Date:  2011-07-26       Impact factor: 3.493

2.  Hippocampus-specific deletion of BDNF in adult mice impairs spatial memory and extinction of aversive memories.

Authors:  S A Heldt; L Stanek; J P Chhatwal; K J Ressler
Journal:  Mol Psychiatry       Date:  2007-01-30       Impact factor: 15.992

Review 3.  NMDA neurotransmission as a critical mediator of borderline personality disorder.

Authors:  Bernadette Grosjean; Guochuan E Tsai
Journal:  J Psychiatry Neurosci       Date:  2007-03       Impact factor: 6.186

4.  Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.

Authors:  Elisabeth B Binder; Rebekah G Bradley; Wei Liu; Michael P Epstein; Todd C Deveau; Kristina B Mercer; Yilang Tang; Charles F Gillespie; Christine M Heim; Charles B Nemeroff; Ann C Schwartz; Joseph F Cubells; Kerry J Ressler
Journal:  JAMA       Date:  2008-03-19       Impact factor: 56.272

Review 5.  Emotion Dysregulation Following Trauma: Shared Neurocircuitry of Traumatic Brain Injury and Trauma-Related Psychiatric Disorders.

Authors:  Carissa N Weis; E Kate Webb; Terri A deRoon-Cassini; Christine L Larson
Journal:  Biol Psychiatry       Date:  2021-07-31       Impact factor: 13.382

6.  Novelty during a late postacquisition time window attenuates the persistence of fear memory.

Authors:  Cynthia Katche; Micol Tomaiuolo; Guido Dorman; Jorge H Medina; Haydee Viola
Journal:  Sci Rep       Date:  2016-10-13       Impact factor: 4.379

7.  Structural covariance of the ventral visual stream predicts posttraumatic intrusion and nightmare symptoms: a multivariate data fusion analysis.

Authors:  Nathaniel G Harnett; Katherine E Finegold; Lauren A M Lebois; Sanne J H van Rooij; Timothy D Ely; Vishnu P Murty; Tanja Jovanovic; Steven E Bruce; Stacey L House; Francesca L Beaudoin; Xinming An; Donglin Zeng; Thomas C Neylan; Gari D Clifford; Sarah D Linnstaedt; Laura T Germine; Kenneth A Bollen; Scott L Rauch; John P Haran; Alan B Storrow; Christopher Lewandowski; Paul I Musey; Phyllis L Hendry; Sophia Sheikh; Christopher W Jones; Brittany E Punches; Michael C Kurz; Robert A Swor; Lauren A Hudak; Jose L Pascual; Mark J Seamon; Erica Harris; Anna M Chang; Claire Pearson; David A Peak; Robert M Domeier; Niels K Rathlev; Brian J O'Neil; Paulina Sergot; Leon D Sanchez; Mark W Miller; Robert H Pietrzak; Jutta Joormann; Deanna M Barch; Diego A Pizzagalli; John F Sheridan; Steven E Harte; James M Elliott; Ronald C Kessler; Karestan C Koenen; Samuel A McLean; Lisa D Nickerson; Kerry J Ressler; Jennifer S Stevens
Journal:  Transl Psychiatry       Date:  2022-08-08       Impact factor: 7.989

8.  Constitutively active Rap2 transgenic mice display fewer dendritic spines, reduced extracellular signal-regulated kinase signaling, enhanced long-term depression, and impaired spatial learning and fear extinction.

Authors:  Jubin Ryu; Kensuke Futai; Monica Feliu; Richard Weinberg; Morgan Sheng
Journal:  J Neurosci       Date:  2008-08-13       Impact factor: 6.167

9.  Group II metabotropic glutamate receptor activation in the basolateral amygdala mediates individual differences in stress-induced changes in rapid eye movement sleep.

Authors:  Brook L W Sweeten; Austin M Adkins; Laurie L Wellman; Larry D Sanford
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2020-06-10       Impact factor: 5.067

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.